Last ¥1,426 JPY
Change Today +16.00 / 1.13%
Volume 86.2K
As of 1:00 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

japan tissue engineering co (7774) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/30/14 - ¥2,330
52 Week Low
04/11/14 - ¥1,166
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for JAPAN TISSUE ENGINEERING CO (7774)

Related News

No related news articles were found.

japan tissue engineering co (7774) Related Businessweek News

No Related Businessweek News Found

japan tissue engineering co (7774) Details

Japan Tissue Engineering Co., Ltd. develops, manufactures, and sells regenerative medicines in Japan. It develops, manufactures, and sells tissue-engineered medical and related products. The company offers autologous cultured epidermis, cartilage, and corneal epithelium to medical institutions for the purpose of medical treatment. Its tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured, and then transplanted back to the same patient. The company is also involved in the research and development of human 3-dimensional cultured tissue models for use in the development of drugs for external use and cosmetics, as well as for various forms of research that makes use of skin and cornea. Japan Tissue Engineering Co., Ltd. was founded in 1999 and is headquartered in Gamagori, Japan.

157 Employees
Last Reported Date: 06/25/14
Founded in 1999

japan tissue engineering co (7774) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

japan tissue engineering co (7774) Key Developments

Japan Tissue Engineering Co., Ltd. Reports Non-Consolidated Earnings Results for the Second Quarter Ended September 30, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015

Japan Tissue Engineering Co., Ltd. reported non-consolidated earnings results for the second quarter ended September 30, 2014. For the quarter, the company reported net sales of JPY 514 million against JPY 419 million a year ago. Operating loss was JPY 526 million against JPY 491 million a year ago. Ordinary loss was JPY 528 million against JPY 494 million a year ago. Net loss was JPY 530 million against JPY 496 million a year ago. Net loss per share was JPY 14.41 against JPY 13.54 a year ago. Loss before income taxes was JPY 528,912,000 against JPY 494,821,000 a year ago. For the year ending March 31, 2015, the company expects sales of JPY 1,275 million, operating loss of JPY 982 million, ordinary loss of JPY 760 million and net loss of JPY 764 million or JPY 20.73 net loss per share.

Japan Tissue Engineering Co., Ltd., Q2 2015 Earnings Call, Oct 31, 2014

Japan Tissue Engineering Co., Ltd., Q2 2015 Earnings Call, Oct 31, 2014

Japan Tissue Engineering Co., Ltd. to Report Q2, 2015 Results on Oct 30, 2014

Japan Tissue Engineering Co., Ltd. announced that they will report Q2, 2015 results on Oct 30, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7774:JP ¥1,426.00 JPY +16.00

7774 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 7774.
View Industry Companies

Industry Analysis


Industry Average

Valuation 7774 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 43.7x
Price/Book 29.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 42.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAPAN TISSUE ENGINEERING CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at